Refractory Constipation
6
3
3
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Optimization of taVNS Intervention Strategies for Refractory Constipation
Transcranial Alternating Current Stimulation for Refractory Constipation With Somatic Symptom Disorder
The Role of Anorectal Manometry in Pediatric Chronic Refractory Constipation
Evaluation of Fluoxetine for Refractory Constipation With Somatic Symptom Disorder Features
Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity Evaluation
Fluoxetine for Refractory Constipation